Sveriges mest populära poddar

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

27 min•7 november 2023

Om avsnittet

Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt

Exchanges med Goldman Sachs finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

Om avsnittet

Fler avsnitt

Why Oil Prices Are Surging Despite Recovering Supply

Where Chinese Exports Are Gaining the Most Market Share

Inside the Revival of Venture Capital Liquidity with an Industry Pioneer

How Family Businesses Should Plan for Generational Success

Why Markets May Be Pricing in Too Many Fed Rate Hikes

Rich Friedman on the Rise of Private Markets and AI Investing

Why Global Bond Yields Are Surging

How Will Less Fed Transparency Affect Markets and the Economy?

Dipan Patel on Permira’s ‘Artisanal’ Approach to Private Equity

The Outlook for Data Center Power Demand as AI Token Use Grows